Wave Life Sciences Ltd. (WVE) Balance Sheet
As of 2026-06-30 (10-Q), Wave Life Sciences Ltd. (WVE) reported total assets of $558.3M, total liabilities of $104.8M and shareholders' equity of $453.5M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $368.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
WVEWave Life Sciences Ltd.Follow WVE — free
—
Price chart with a free account
- Market cap
- 626.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 161.2 | 150.3 | 142.5 | 174.8 | 147.2 | 184.5 | 150.6 | 88.5 | 200.4 | 302.1 | 602.1 | 368.0 | |
| Receivables | — | — | 1.0 | 10.0 | 20.0 | 30.0 | — | — | 21.1 | 1.4 | 1.3 | 0.9 | |
| Current assets | 161.4 | 152.0 | 150.5 | 202.3 | 185.5 | 230.0 | 162.6 | 98.5 | 235.4 | 320.4 | 614.8 | 507.5 | |
| Total assets | 165.4 | 164.8 | 181.8 | 295.9 | 284.3 | 279.2 | 207.0 | 146.4 | 274.9 | 352.2 | 638.5 | 558.3 | |
| Current liabilities | 3.8 | 12.2 | 18.2 | 130.0 | 118.2 | 121.0 | 64.2 | 71.5 | 186.4 | 111.0 | 95.1 | 50.8 | |
| Total liabilities | 4.1 | 22.1 | 34.4 | 214.7 | 212.6 | 188.6 | 166.6 | 183.6 | 227.4 | 134.8 | 112.3 | 104.8 | |
| Shareholders' equity | 153.5 | 134.6 | 139.6 | 73.3 | 63.7 | 82.8 | 32.5 | -45.1 | 39.6 | 209.5 | 518.4 | 453.5 |
USD millions · SEC XBRL
Wave Life Sciences Ltd. — questions
- How much cash does Wave Life Sciences Ltd. have?
- $368.0M in cash and cash equivalents as of 2026-06-30.
- What are Wave Life Sciences Ltd.'s total assets?
- $558.3M as of 2026-06-30.
- What is Wave Life Sciences Ltd.'s shareholders' equity?
- $453.5M as of 2026-06-30.
Every figure on this page comes from Wave Life Sciences Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.